{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:31:17Z","timestamp":1771651877054,"version":"3.50.1"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Monbl Augenheilkd"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Virale anteriore Uveitiden (AU) lassen sich anhand der charakteristischen Befundkonstellationen (Vorderkammerreiz, Morphologie der Keratopr\u00e4zipitate, Ausma\u00df des IOD-Anstiegs im Schub) oft\n\t\t\t\t\tgut klinisch differenzieren. Bei differenzialdiagnostischen Schwierigkeiten hilft die Vorderkammerpunktion mit Durchf\u00fchrung einer virusspezifischen PCR und\/oder die Antik\u00f6rperbestimmung\n\t\t\t\t\t(Goldmann-Witmer-Koeffizient), wobei beide Techniken spezifisch sind, aber keine absolute Sensitivit\u00e4t besitzen. Therapiert wird bei HSV, VZV und CMV immer kombiniert antiviral und\n\t\t\t\t\tantiinflammatorisch sowie ggf. drucksenkend, wohingegen f\u00fcr die Rubella-assoziierte AU kein spezifisches Virustatikum existiert und Steroide aufgrund der unerw\u00fcnschten Wirkungen \u00e4u\u00dferst\n\t\t\t\t\tzur\u00fcckhaltend eingesetzt werden sollten. Problematisch bei allen Formen der viralen AU ist das Risiko der Sekund\u00e4rglaukomentwicklung im Falle rezidivierender Episoden, das nicht selten\n\t\t\t\t\toperativ behandelt werden muss.<\/jats:p>","DOI":"10.1055\/a-1710-3473","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:56:03Z","timestamp":1648079763000},"page":"659-665","source":"Crossref","is-referenced-by-count":3,"title":["Virale anteriore Uveitis"],"prefix":"10.1055","volume":"239","author":[{"given":"Karoline","family":"Baquet-Walscheid","sequence":"additional","affiliation":[{"name":"Augenzentrum am St.\u2009Franziskus-Hospital, M\u00fcnster, Deutschland"},{"name":"Medizinische Fakult\u00e4t der Universit\u00e4t Duisburg-Essen, Essen, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Pohlmann","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Campus Virchow-Klinik, Universit\u00e4ts-Augenklinik, Berlin, Deutschland"},{"name":"Berliner Institut f\u00fcr Gesundheitsforschung, Berlin, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5569-1473","authenticated-orcid":false,"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[{"name":"Charit\u00e9 \u2013 Campus Virchow-Klinik, Universit\u00e4ts-Augenklinik, Berlin, Deutschland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1853177","article-title":"Epidemiology of Viral Induced\u00a0Anterior Uveitis","author":"A Radosavljevic","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2147\/OPTH.S60394","article-title":"Current aspects on the management of viral uveitis in immunocompetent individuals","volume":"9","author":"U Pleyer","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004397-200004000-00008","article-title":"Advances in diagnosis and management of herpetic uveitis","volume":"40","author":"B D Gaynor","year":"2000","journal-title":"Int Ophthalmol Clin"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e0199301","DOI":"10.1371\/journal.pone.0199301","article-title":"Different composition of intraocular immune mediators in Posner-Schlossman-Syndrome and Fuchs\u02bc Uveitis","volume":"13","author":"D Pohlmann","year":"2018","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop","volume":"140","author":"D A Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ajo.2021.03.053","article-title":"Classification Criteria for Herpes Simplex Virus Anterior Uveitis","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajo.2021.03.037","article-title":"Classification Criteria for Varicella Zoster Virus Anterior Uveitis","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajo.2021.03.060","article-title":"Classification Criteria for Cytomegalovirus Anterior Uveitis","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajo.2021.03.052","article-title":"Classification Criteria for Fuchs Uveitis Syndrome","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/ceo.13417","article-title":"Demystifying viral anterior uveitis: A review","volume":"47","author":"N S Chan","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/09273948.2018.1468470","article-title":"Differential Diagnosis of Viral-Induced Anterior Uveitis","volume":"26","author":"L J Relvas","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajo.2007.12.015","article-title":"Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients","volume":"145","author":"S P Chee","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09273948.2017.1394471","article-title":"Clinical Features of CMV-Associated Anterior Uveitis","volume":"26","author":"N S Chan","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e0229260","DOI":"10.1371\/journal.pone.0229260","article-title":"Virus-associated anterior uveitis and secondary glaucoma: Diagnostics, clinical characteristics, and surgical options","volume":"15","author":"D Pohlmann","year":"2020","journal-title":"PLoS One"},{"key":"ref15","first-page":"83","article-title":"[Anterior viral uveitis: Clinical aspects, diagnostic procedure and treatment options]","volume":"117","author":"M Lenglinger","year":"2020","journal-title":"Ophthalmologe"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ajo.2005.07.078","article-title":"Rubella virus is associated with Fuchs heterochromic iridocyclitis","volume":"141","author":"J D de Groot-Mijnes","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00417-009-1239-7","article-title":"Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs\u02bc heterochromic cyclitis","volume":"248","author":"P C Ruokonen","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajo.2004.02.055","article-title":"Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor","volume":"138","author":"C D Quentin","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/09273948.2017.1411952","article-title":"Diagnosis of Cytomegalovirus Anterior Uveitis in Two European Referral Centers","volume":"26","author":"L JM Relvas","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ajo.2005.09.017","article-title":"Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis","volume":"141","author":"J D De Groot-Mijnes","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3390\/molecules26041132","article-title":"Advances and Perspectives in the Management of Varicella-Zoster Virus Infections","volume":"26","author":"G Andrei","year":"2021","journal-title":"Molecules"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcv.2013.03.014","article-title":"Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients","volume":"57","author":"M van Velzen","year":"2013","journal-title":"J Clin Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajo.2014.08.007","article-title":"Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy","volume":"158","author":"C C Su","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12348-016-0078-z","article-title":"Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis","volume":"6","author":"J X Wong","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41598-021-82637-y","article-title":"Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results","volume":"11","author":"Y C Cheng","year":"2021","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00417-009-1195-2","article-title":"Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis","volume":"248","author":"Y S Hwang","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.017","article-title":"Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States","author":"A Lu","year":"2021","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.05.026","article-title":"Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program","volume":"144","author":"A D Birnbaum","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1710-3473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T22:43:37Z","timestamp":1652222617000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1710-3473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":28,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,5,10]]},"published-print":{"date-parts":[[2022,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1710-3473","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0023-2165","1439-3999"],"issn-type":[{"value":"0023-2165","type":"print"},{"value":"1439-3999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]}}}